As the pace of the COVID-19 vaccine rollout accelerates, the roles of various players continue to evolve among government, public companies, and private entities. Pharmaceutical and supply manufacturers, healthcare service providers, educators, advertisers, transportation and logistics providers, and many others are constantly assessing and reassessing the changing dynamic for their industries and organizations. But what opportunities, regulatory considerations, and legal obstacles still lie ahead?
From digital passports to data privacy to supply chain management, the rollout of the COVID-19 vaccine and modified vaccines will continue to generate novel challenges, particularly as the delivery system moves to a more private sector model. Join us for a series of webinars that will explore the legal and regulatory issues arising for businesses that have become increasingly central to rolling out vaccines in the United States and around the globe.
CLE credit in CA, IL, NY, PA, TX, and VA is currently pending approval. Credit in CT, FL, and NJ is pending approval (via reciprocity).
Partners Barbara Melby, Peter Watt-Morse, and Mike Pierides will discuss issues and practical pointers that are especially important for technology, outsourcing, and commercial agreements related to the continuing pandemic and vaccine rollout. This session features an annual review of highlights from the Contract Corner feature on our Tech & Sourcing @ Morgan Lewis blog series.
Partners Giovanna Cinelli, Kathy Sanzo, and Doneld Shelkey will discuss legal challenges in regards to the vaccine supply chain, manufacturing and licensing.
Partners Reece Hirsch, Pulina Whitaker, and Beth Herrington will discuss cybersecurity and data privacy legal issues related to IT infrastructure and systems employed in the vaccine rollout.
Partners Susan Feigin Harris, John Lavelle, and Kathleen McDermott will explore legal issues related to liability and insurance in terms of the vaccine.
Partners Reece Hirsch and Pulina Whitaker will discuss legal challenges in regards to digital vaccine passports.